The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) 36E79724R0032 for the procurement of Ketoconazole 2% Cream, intended for various federal healthcare services, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The solicitation is scheduled for release around October 10, 2024, with a response deadline of October 24, 2024. The contract will cover one year with four optional one-year extensions, with a focus on maintaining an uninterrupted supply of the drug. Interested vendors must provide specific product naming and unique NDC numbers. Estimated annual requirements include approximately 62,643 tubes of 15 GM, 233,385 tubes of 30 GM, and 139,890 tubes of 60 GM. Detailed updates and potential amendments will be available electronically on www.beta.sam.gov, and no physical documents will be distributed. Questions regarding the solicitation can be directed to the designated contact, Michael Olszewski, via email.
This document outlines an acquisition solicitation by the Department of Veterans Affairs (VA) for a contract related to the supply of Ketoconazole 2% Cream, encompassing various quantities for both immediate and option years. The solicitation specifies that bids must include prices for the base year and all four option years, as well as compliance with the Cost Recovery Fee of 0.5%.
The award will be made in aggregate for multiple line items, and offerors must provide unique National Drug Codes (NDC) for the products proposed. The document emphasizes that only manufacturers or authorized distributors with acceptable FDA cGMP statuses will be considered for contract award.
It also outlines essential conditions such as potential recalls, the Drug Supply Chain Security Act compliance, and required reporting mechanisms for contract sales and Cost Recovery Fees. Offerors need to maintain agreements with Prime Vendor Programs for distribution, with specified evaluation criteria based on FAR regulations. The document is structured to provide detailed solicitation information, contract terms, and stipulations for manufacturers, ensuring clarity and compliance required for government procurement processes. This RFP reflects the VA's initiative to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards.